Search
Back

Ferric Carboxymaltose

CAS C39H63FeO39
Ferric Carboxymaltose

General Information

Ferric Carboxymaltose is an iron replacement therapy used to treat iron deficiency anemia in children and adults with intolerance or inadequate clinical response to oral iron, and in adult patients who have non-dialysis dependent chronic kidney disease.


About the API

Molecular Formula C39H63FeO39
Therapeutic category Hematology
Systematic Name iron(III)(2R,3R,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-(((2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-4-ylcarbonatebis((2R,3R,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-(((2S,3R,4S,5S,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-4-yl carbonate)

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.